Free Trial

Point72 Asset Management L.P. Buys New Shares in AMERISAFE, Inc. (NASDAQ:AMSF)

AMERISAFE logo with Finance background

Point72 Asset Management L.P. acquired a new stake in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 9,484 shares of the insurance provider's stock, valued at approximately $489,000.

A number of other large investors have also added to or reduced their stakes in the stock. Nuveen Asset Management LLC raised its stake in AMERISAFE by 92.1% during the fourth quarter. Nuveen Asset Management LLC now owns 161,815 shares of the insurance provider's stock valued at $8,340,000 after buying an additional 77,582 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of AMERISAFE by 3.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,842 shares of the insurance provider's stock worth $559,000 after purchasing an additional 357 shares in the last quarter. Lazard Asset Management LLC bought a new stake in shares of AMERISAFE in the 4th quarter worth $43,000. Deutsche Bank AG increased its holdings in shares of AMERISAFE by 52.0% in the 4th quarter. Deutsche Bank AG now owns 18,610 shares of the insurance provider's stock worth $959,000 after purchasing an additional 6,366 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in shares of AMERISAFE by 7.8% in the 4th quarter. Ameriprise Financial Inc. now owns 102,843 shares of the insurance provider's stock worth $5,301,000 after purchasing an additional 7,399 shares in the last quarter. Hedge funds and other institutional investors own 97.41% of the company's stock.

AMERISAFE Stock Up 1.3%

Shares of AMERISAFE stock traded up $0.59 on Tuesday, reaching $46.98. The company's stock had a trading volume of 76,263 shares, compared to its average volume of 109,384. The company has a market capitalization of $894.97 million, a price-to-earnings ratio of 14.68 and a beta of 0.41. The firm's fifty day simple moving average is $49.00 and its two-hundred day simple moving average is $51.32. AMERISAFE, Inc. has a 52 week low of $41.97 and a 52 week high of $60.24.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last posted its earnings results on Tuesday, April 29th. The insurance provider reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.59 by $0.01. AMERISAFE had a return on equity of 16.50% and a net margin of 19.49%. The business had revenue of $83.78 million during the quarter, compared to analyst estimates of $76.66 million. As a group, research analysts predict that AMERISAFE, Inc. will post 2.45 EPS for the current year.

AMERISAFE Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 13th will be issued a $0.39 dividend. This represents a $1.56 annualized dividend and a dividend yield of 3.32%. The ex-dividend date of this dividend is Friday, June 13th. AMERISAFE's payout ratio is currently 62.90%.

Analyst Upgrades and Downgrades

Separately, JMP Securities reissued a "market outperform" rating and issued a $65.00 target price on shares of AMERISAFE in a report on Wednesday, April 30th.

Read Our Latest Report on AMSF

AMERISAFE Profile

(Free Report)

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.

Featured Articles

Institutional Ownership by Quarter for AMERISAFE (NASDAQ:AMSF)

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines